pantoprazole has been researched along with Hypertension in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| " She had been on dabigatran for 13 months due to atrial fibrillation and arterial hypertension." | 7.81 | [Exfoliative esophagitis while taking dabigatran]. ( Meesmann, M; Scheppach, W, 2015) |
| " She had been on dabigatran for 13 months due to atrial fibrillation and arterial hypertension." | 3.81 | [Exfoliative esophagitis while taking dabigatran]. ( Meesmann, M; Scheppach, W, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rattanasupar, A | 1 |
| Sengmanee, S | 1 |
| Scheppach, W | 1 |
| Meesmann, M | 1 |
1 trial available for pantoprazole and Hypertension
| Article | Year |
|---|---|
Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Intravenous; Dose-Response Relationship, Dr | 2016 |
1 other study available for pantoprazole and Hypertension
| Article | Year |
|---|---|
[Exfoliative esophagitis while taking dabigatran].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antithrombins; Atrial Fibrillation | 2015 |